|
J. Biol. Chem., Vol. 263, Issue 31, 16039-16044, 11, 1988
Ca2+ priming during vitamin D-induced monocytic differentiation of a human leukemia cell line
KA Hruska, Z Bar-Shavit, JD Malone and S Teitelbaum
Department of Medicine, Jewish Hospital, Washington University Medical Center, St. Louis, Missouri 63110.
1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3) induces monocytic differentiation
of the human promyelocytic leukemia line, HL-60, and enhances Ca2+
transport in target cells of the mineral metabolism system. Hence, we
determined whether the steroid's maturational effect on HL-60 involves
alterations of intracellular calcium [( Ca2+]i). We found that, as detected
by indo-1 fluorescence, [Ca2+]i increases in a slow tonic manner from 99
+/- 11 nM in virgin HL-60 to 182 +/- 19 nM (p less than 0.001) in those
treated with 1,25-(OH)2D3 for 24 h. The first apparent rise in [Ca2+]i
occurs at between 6 and 12 h and parallels expression of alpha-thrombin and
N-formyl-methionyl-leucyl- phenylalanine (fMLP) receptors. This increase in
[Ca2+]i is derived from extracellular calcium as its reduction abolishes
the effect. The increase in [Ca2+]i is associated with an increase in
inositol trisphosphate-stimulated Ca2+ flux from intracellular stores.
Interestingly, 1,25-(OH)2D3-mediated HL-60 differentiation as manifest by
expression of the macrophage-specific antigen, 63D3, is not blocked by low
extracellular calcium. In contrast, the fMLP-induced superoxide ion
generation is diminished if the increase in [Ca2+]i is prevented.
Furthermore, fMLP-stimulated signal transduction is also reduced by
limiting the stimulation of [Ca2+]i during 1,25-(OH)2D3 treatment. Thus,
although differentiation of HL-60 to the monocytic phenotype by
1,25-(OH)2D3 is Ca2+-independent, expression of response to regulatory
stimuli requires priming of cellular Ca2+ stores. The latter appears to be
induced by 1,25-(OH)2D3 via stimulated Ca2+ entry through the plasma
membrane.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. S. Dusso, A. J. Brown, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol,
July 1, 2005;
289(1):
F8 - F28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski
Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium
Cancer Res.,
March 15, 2003;
63(6):
1325 - 1332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Berry and K. A. Meckling-Gill
Vitamin D Analogs, 20-Epi-22-Oxa-24a,26a,27a,-Trihomo-1{alpha},25(OH)2-Vitamin D3, 1,24(OH)2-22-Ene-24-Cyclopropyl-Vitamin D3 and 1{alpha},25(OH)2-Lumisterol3 Prime NB4 Leukemia Cells for Monocytic Differentiation via Nongenomic Signaling Pathways, Involving Calcium and Calpain
Endocrinology,
October 1, 1999;
140(10):
4779 - 4788.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J. Brown, A. Dusso, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol,
August 1, 1999;
277(2):
F157 - F175.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|